Dexcom Inc Stock Price Prediction

DXCM Stock  USD 124.34  13.67  9.91%   
As of now, The relative strength index (RSI) of DexCom's share price is at 52 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling DexCom, making its price go up or down.

Oversold Vs Overbought

52

 
Oversold
 
Overbought
DexCom Inc stock price prediction is an act of determining the future value of DexCom shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of DexCom's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of DexCom and does not consider all of the tangible or intangible factors available from DexCom's fundamental data. We analyze noise-free headlines and recent hype associated with DexCom Inc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting DexCom's stock price prediction:
Quarterly Earnings Growth
1.81
EPS Estimate Next Quarter
0.28
EPS Estimate Current Year
1.76
EPS Estimate Next Year
2.24
Wall Street Target Price
151.32
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of DexCom based on different types of headlines from major news networks to social media. The DexCom stock price prediction module provides an analysis of price elasticity to changes in media outlook on DexCom over a specific investment horizon. Using DexCom hype-based prediction, you can estimate the value of DexCom Inc from the perspective of DexCom response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards DexCom using DexCom's stock options and short interest. It helps to benchmark the overall future attitude of investors towards DexCom using crowd psychology based on the activity and movement of DexCom's stock price.

DexCom Short Interest

A significant increase or decrease in DexCom's short interest from the previous month could be a good indicator of investor sentiment towards DexCom. Short interest can provide insight into the potential direction of DexCom stock and how bullish or bearish investors feel about the market overall. An investor who is long DexCom may also wish to track short interest. As short interest increases, investors should be becoming more worried about DexCom and may potentially protect profits, hedge DexCom with its derivative instruments, or be ready for some potential downside.
200 Day MA
115.0664
Short Percent
0.0428
Short Ratio
4.32
Shares Short Prior Month
14.6 M
50 Day MA
129.7472

DexCom Inc Hype to Price Pattern

Investor biases related to DexCom's public news can be used to forecast risks associated with an investment in DexCom. The trend in average sentiment can be used to explain how an investor holding DexCom can time the market purely based on public headlines and social activities around DexCom Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of DexCom's market sentiment to its price can help taders to make decisions based on the overall investors consensus about DexCom.

DexCom Implied Volatility

    
  74.82  
DexCom's implied volatility exposes the market's sentiment of DexCom Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if DexCom's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that DexCom stock will not fluctuate a lot when DexCom's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in DexCom. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in DexCom to buy its stock at a price that has no basis in reality. In that case, they are not buying DexCom because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

DexCom after-hype prediction price

    
  USD 124.25  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current DexCom contract

Based on the Rule 16, the options market is currently suggesting that DexCom Inc will have an average daily up or down price movement of about 4.68% per day over the life of the 2024-04-26 option contract. With DexCom trading at USD 124.34, that is roughly USD 5.81 . If you think that the market is fully incorporating DexCom's daily price movement you should consider acquiring DexCom Inc options at the current volatility level of 74.82%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out DexCom Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
111.91131.41133.67
Details
Naive
Forecast
LowNextHigh
131.37133.62135.88
Details
24 Analysts
Consensus
LowTargetHigh
124.67137.00152.07
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.210.270.34
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DexCom. Your research has to be compared to or analyzed against DexCom's peers to derive any actionable benefits. When done correctly, DexCom's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DexCom Inc.

DexCom After-Hype Price Prediction Density Analysis

As far as predicting the price of DexCom at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in DexCom or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of DexCom, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

DexCom Estimiated After-Hype Price Volatility

In the context of predicting DexCom's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on DexCom's historical news coverage. DexCom's after-hype downside and upside margins for the prediction period are 121.99 and 126.51, respectively. We have considered DexCom's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
124.34
121.99
Downside
124.25
After-hype Price
126.51
Upside
DexCom is very steady at this time. Analysis and calculation of next after-hype price of DexCom Inc is based on 3 months time horizon.

DexCom Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as DexCom is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DexCom backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with DexCom, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.19 
2.26
  0.09 
  0.09 
11 Events / Month
1 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
124.34
124.25
0.07 
470.83  
Notes

DexCom Hype Timeline

DexCom Inc is currently traded for 124.34. The entity has historical hype elasticity of -0.09, and average elasticity to hype of competition of -0.09. DexCom is forecasted to decline in value after the next headline, with the price expected to drop to 124.25. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.07%, whereas the daily expected return is currently at 0.19%. The volatility of related hype on DexCom is about 456.57%, with the expected price after the next announcement by competition of 124.25. About 100.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.53. DexCom Inc had not issued any dividends in recent years. The entity had 4:1 split on the 13th of June 2022. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days.
Check out DexCom Basic Forecasting Models to cross-verify your projections.

DexCom Related Hype Analysis

Having access to credible news sources related to DexCom's direct competition is more important than ever and may enhance your ability to predict DexCom's future price movements. Getting to know how DexCom's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how DexCom may potentially react to the hype associated with one of its peers.

DexCom Additional Predictive Modules

Most predictive techniques to examine DexCom price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DexCom using various technical indicators. When you analyze DexCom charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About DexCom Predictive Indicators

The successful prediction of DexCom stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as DexCom Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of DexCom based on analysis of DexCom hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to DexCom's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DexCom's related companies.
 2021 2022 2023 2024 (projected)
Payables Turnover1.341.144.828.14
Days Of Inventory On Hand169.81109.03153.18160.84

Story Coverage note for DexCom

The number of cover stories for DexCom depends on current market conditions and DexCom's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that DexCom is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about DexCom's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

DexCom Short Properties

DexCom's future price predictability will typically decrease when DexCom's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of DexCom Inc often depends not only on the future outlook of the potential DexCom's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. DexCom's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding425.5 M
Cash And Short Term Investments2.7 B
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out DexCom Basic Forecasting Models to cross-verify your projections.
Note that the DexCom Inc information on this page should be used as a complementary analysis to other DexCom's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Is DexCom's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.81
Earnings Share
1.34
Revenue Per Share
9.384
Quarterly Revenue Growth
0.269
Return On Assets
0.0641
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.